Nicholas Investment Partners, LP Intra Cellular Therapies, Inc. Transaction History

Nicholas Investment Partners, LP

$900 Million
Q3 2024

A detailed history of Nicholas Investment Partners, LP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 154,798 shares of ITCI stock, worth $13 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares

154,798

Previous 151,409 2.24%

Holding current value

$13 Million

Previous $10.4 Million 9.14%

% of portfolio

1.26%

Previous 1.23%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$67.99 - $80.84 $230,418 - $273,966	3,389 Added 2.24%	154,798 $11.3 Million
Q2 2024 Aug 07, 2024	BUY	$64.76 - $79.84 $5.18 Million - $6.39 Million	80,038 Added 112.14%	151,409 $10.4 Million
Q1 2024 May 13, 2024	BUY	$64.37 - $75.65 $1.36 Million - $1.6 Million	21,127 Added 42.05%	71,371 $4.94 Million
Q4 2023 Feb 07, 2024	SELL	$46.37 - $73.65 $13.2 Million - $21 Million	-285,310 Reduced 85.03%	50,244 $3.6 Million
Q3 2023 Nov 13, 2023	SELL	$52.09 - $64.1 $8.54 Million - $10.5 Million	-163,949 Reduced 32.82%	335,554 $17.5 Million
Q2 2023 Aug 09, 2023	BUY	$54.67 - $66.44 $27.3 Million - $33.2 Million	499,503 New	499,503 $31.6 Million
Q4 2022 Feb 10, 2023	BUY	$44.07 - $54.45 $1.01 Million - $1.24 Million	22,829 Added 5.84%	413,507 $21.9 Million
Q3 2022 Nov 14, 2022	SELL	$42.7 - $59.99 $1.85 Million - $2.6 Million	-43,281 Reduced 9.97%	390,678 $18.2 Million
Q2 2022 Aug 10, 2022	SELL	$43.0 - $65.64 $5.52 Million - $8.43 Million	-128,414 Reduced 22.83%	433,959 $24.8 Million
Q1 2022 May 10, 2022	SELL	$38.74 - $62.09 $3.51 Million - $5.62 Million	-90,513 Reduced 13.86%	562,373 $34.4 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $53.42 $1.4 Million - $2.12 Million	39,674 Added 6.47%	652,886 $34.2 Million
Q3 2021 Nov 15, 2021	BUY	$28.72 - $42.49 $429,392 - $635,267	14,951 Added 2.5%	613,212 $22.9 Million
Q2 2021 Aug 10, 2021	BUY	$29.3 - $44.5 $1.28 Million - $1.95 Million	43,716 Added 7.88%	598,261 $24.4 Million
Q1 2021 May 14, 2021	BUY	$30.8 - $39.51 $5.06 Million - $6.49 Million	164,256 Added 42.09%	554,545 $18.8 Million
Q4 2020 Feb 11, 2021	SELL	$23.34 - $32.22 $1.57 Million - $2.17 Million	-67,431 Reduced 14.73%	390,289 $12.4 Million
Q3 2020 Nov 13, 2020	BUY	$17.61 - $31.86 $8.06 Million - $14.6 Million	457,720 New	457,720 $11.7 Million

Others Institutions Holding ITCI

# of Institutions

377

Shares Held

84.1M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.94B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Account

Nicholas Investment Partners, LP Intra Cellular Therapies, Inc. Transaction History